Listed here are three shares with purchase rank and robust revenue traits for buyers to contemplate right this moment, July 15th:

Unbiased Financial institution Company IBCP: This financial institution holding firm for Unbiased Financial institution has witnessed the Zacks Consensus Estimate for its present 12 months earnings growing 0.4% over the past 60 days.

Unbiased Financial institution Company Worth and Consensus

Unbiased Financial institution Company price-consensus-chart | Unbiased Financial institution Company Quote

This Zacks Rank #1 firm has a dividend yield of 4.7%, in contrast with the trade common of two.8%.

Unbiased Financial institution Company Dividend Yield (TTM)

Unbiased Financial institution Company dividend-yield-ttm | Unbiased Financial institution Company Quote

Petróleo Brasileiro S.A. – Petrobras PBR: This explorer and producer of oil and fuel has witnessed the Zacks Consensus Estimate for its present 12 months earnings growing 5.6% over the past 60 days.

Petroleo Brasileiro S.A. Petrobras Worth and Consensus

Petroleo Brasileiro S.A. Petrobras price-consensus-chart | Petroleo Brasileiro S.A. Petrobras Quote

This Zacks Rank #1 firm has a dividend yield of 27.2%, in contrast with the trade common of almost 24%.

Petroleo Brasileiro S.A. Petrobras Dividend Yield (TTM)

Petroleo Brasileiro S.A. Petrobras dividend-yield-ttm | Petroleo Brasileiro S.A. Petrobras Quote

Merck & Co., Inc. MRK: This healthcare firm has witnessed the Zacks Consensus Estimate for its present 12 months earnings growing 0.4% over the past 60 days.

Merck & Co., Inc. Worth and Consensus

Merck & Co., Inc. price-consensus-chart | Merck & Co., Inc. Quote

This Zacks Rank #1 firm has a dividend yield of two.9%, in contrast with the trade common of two.5%.

Merck & Co., Inc. Dividend Yield (TTM)

Merck & Co., Inc. dividend-yield-ttm | Merck & Co., Inc. Quote

See the full listing of prime ranked shares right here.

Discover extra prime revenue shares with a few of our nice premium screens.

Zacks Names “Single Greatest Decide to Double”

From hundreds of shares, 5 Zacks specialists every have chosen their favourite to skyrocket +100% or extra in months to come back. From these 5, Director of Analysis Sheraz Mian hand-picks one to have essentially the most explosive upside of all.

It’s a little-known chemical firm that’s up 65% over final 12 months, but nonetheless grime low cost. With unrelenting demand, hovering 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail buyers may bounce in at any time.

This firm may rival or surpass different latest Zacks’ Shares Set to Double like Boston Beer Firm which shot up +143.0% in little greater than 9 months and NVIDIA which boomed +175.9% in a single 12 months.

Free: See Our Prime Inventory and Four Runners Up >>

Click on to get this free report

Petroleo Brasileiro S.A. Petrobras (PBR): Free Inventory Evaluation Report

Merck & Co., Inc. (MRK): Free Inventory Evaluation Report

Unbiased Financial institution Company (IBCP): Free Inventory Evaluation Report

To learn this text on Zacks.com click on right here.

Zacks Funding Analysis

The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.